Okihide Suzuki1, Hidetaka Eguchi2, Noriyasu Chika1, Takehiko Sakimoto1, Keiichiro Ishibashi1, Kensuke Kumamoto1, Jun-Ichi Tamaru3, Tetsuhiko Tachikawa4, Kiwamu Akagi4, Tomio Arai5, Yasushi Okazaki6, Hideyuki Ishida7. 1. Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. 2. Genomic Research Center, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan. 3. Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan. 4. Department of Cancer Prevention and Molecular Genetics, Saitama Prefectural Cancer Center, Saitama, Japan. 5. Department of Pathology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan. 6. Genomic Research Center, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan. okazaki@saitama-med.ac.jp. 7. Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. 05hishi@saitama-med.ac.jp.
Abstract
PURPOSE: To clarify the prevalence and clinicopathologic/molecular characteristics of mismatch repair (MMR)-deficient colorectal cancer in the young Japanese population. METHODS: Immunohistochemical analyses for MMR proteins (MLH1, MSH2, MSH6, and PMS2) were performed in formalin-fixed paraffin-embedded sections prepared from the resected CRC specimens of 119 consecutive patients aged <50 years old, who underwent resection of the primary tumor at our institution between 1996 and 2015. Analyses for somatic BRAF V600E mutation, somatic hypermethylation of the MLH1 promoter, and germline MMR gene mutations were undertaken where indicated. RESULTS: MMR protein loss was found in 10 patients (8.4%), 7 (5.9%) of whom were subsequently identified to have Lynch syndrome (LS). The remaining 3 patients were categorized as having sporadic MMR-deficient CRC (n = 2) or "possible LS (n = 1)". In multivariate logistic regression analysis, the presence of tumor-infiltrating lymphocytes (P < 0.01), right-sided location of the tumor (P = 0.01), and a history of LS-associated tumors in the first-degree relatives (P < 0.01) were identified as independent factors predictive of MMR-deficient CRC. CONCLUSION: These results are of value in the clinical management of patients with the early onset CRC under circumstances where universal tumor screening approaches for LS are still not available, like in Japan.
PURPOSE: To clarify the prevalence and clinicopathologic/molecular characteristics of mismatch repair (MMR)-deficient colorectal cancer in the young Japanese population. METHODS: Immunohistochemical analyses for MMR proteins (MLH1, MSH2, MSH6, and PMS2) were performed in formalin-fixed paraffin-embedded sections prepared from the resected CRC specimens of 119 consecutive patients aged <50 years old, who underwent resection of the primary tumor at our institution between 1996 and 2015. Analyses for somatic BRAFV600E mutation, somatic hypermethylation of the MLH1 promoter, and germline MMR gene mutations were undertaken where indicated. RESULTS: MMR protein loss was found in 10 patients (8.4%), 7 (5.9%) of whom were subsequently identified to have Lynch syndrome (LS). The remaining 3 patients were categorized as having sporadic MMR-deficient CRC (n = 2) or "possible LS (n = 1)". In multivariate logistic regression analysis, the presence of tumor-infiltrating lymphocytes (P < 0.01), right-sided location of the tumor (P = 0.01), and a history of LS-associated tumors in the first-degree relatives (P < 0.01) were identified as independent factors predictive of MMR-deficient CRC. CONCLUSION: These results are of value in the clinical management of patients with the early onset CRC under circumstances where universal tumor screening approaches for LS are still not available, like in Japan.
Entities:
Keywords:
Colorectal cancer; Immunohistochemistry; Lynch syndrome; Mismatch repair deficiency; Young population
Authors: Steven A Lee-Kong; Arnold J Markowitz; Emily Glogowski; Christopher Papadopoulos; Zsofia Stadler; Martin R Weiser; Larissa K Temple; José G Guillem Journal: Clin Colorectal Cancer Date: 2010-10 Impact factor: 4.481
Authors: S Acharya; T Wilson; S Gradia; M F Kane; S Guerrette; G T Marsischky; R Kolodner; R Fishel Journal: Proc Natl Acad Sci U S A Date: 1996-11-26 Impact factor: 11.205
Authors: Judith Balmaña; David H Stockwell; Ewout W Steyerberg; Elena M Stoffel; Amie M Deffenbaugh; Julia E Reid; Brian Ward; Thomas Scholl; Brant Hendrickson; John Tazelaar; Lynn Anne Burbidge; Sapna Syngal Journal: JAMA Date: 2006-09-27 Impact factor: 56.272
Authors: Deborah M Wright; Julie L Arnold; Bryan Parry; Michael Hulme-Moir; Ingrid M Winship; Susan Parry Journal: Dis Colon Rectum Date: 2011-05 Impact factor: 4.585
Authors: C Lamberti; E Mangold; C Pagenstecher; M Jungck; D Schwering; M Bollmann; J Vogel; D Kindermann; R Nikorowitsch; N Friedrichs; B Schneider; F Houshdaran; I G H Schmidt-Wolf; W Friedl; P Propping; T Sauerbruch; R Büttner; M Mathiak Journal: Digestion Date: 2006-03-03 Impact factor: 3.216
Authors: L A Aaltonen; P Peltomäki; J P Mecklin; H Järvinen; J R Jass; J S Green; H T Lynch; P Watson; G Tallqvist; M Juhola Journal: Cancer Res Date: 1994-04-01 Impact factor: 12.701
Authors: Mark A Jenkins; Shinichi Hayashi; Anne-Marie O'Shea; Lawrence J Burgart; Tom C Smyrk; David Shimizu; Paul M Waring; Andrew R Ruszkiewicz; Aaron F Pollett; Mark Redston; Melissa A Barker; John A Baron; Graham R Casey; James G Dowty; Graham G Giles; Paul Limburg; Polly Newcomb; Joanne P Young; Michael D Walsh; Stephen N Thibodeau; Noralane M Lindor; Loïc Lemarchand; Steven Gallinger; Robert W Haile; John D Potter; John L Hopper; Jeremy R Jass Journal: Gastroenterology Date: 2007-04-25 Impact factor: 22.682
Authors: George Kunnackal John; Vipin Das Villgran; Christine Caufield-Noll; Francis Giardiello Journal: Fam Cancer Date: 2020-09-11 Impact factor: 2.375
Authors: Muhammad Usman Rashid; Humaira Naeemi; Noor Muhammad; Asif Loya; Jan Lubiński; Anna Jakubowska; Muhammed Aasim Yusuf Journal: Hered Cancer Clin Pract Date: 2019-10-23 Impact factor: 2.857